Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with amnestic Mild Cognitive Impairment (a type of memory-related condition) or Alzheimer's Disease, based on clinical assessments.
- People who are already having a brain MRI scan at IRCCS Policlinico San Donato as part of their normal diagnostic care.
- Healthy individuals whose age and gender match those of participants with the above diagnoses, included for comparison purposes.
Who may not be able to join:
- People whose cognitive or memory difficulties are caused by a condition other than amnestic Mild Cognitive Impairment or Alzheimer's Disease.
- People who have a significant history of neurological conditions (other than Mild Cognitive Impairment or Alzheimer's Disease) that could affect the study results.
- People for whom having an MRI scan is not medically safe or suitable.
- People with a serious medical or psychiatric condition that, in the researchers' judgement, could interfere with taking part in the study or affect the reliability of the results.
- People with a known history of alcohol or substance misuse that may affect memory or cognitive function.
- People who are unable or unwilling to give their formal consent to take part in the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
White Matter Hyperintensity burden
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.